论文部分内容阅读
目的 :探讨肾移植患者避免长期使用激素的可能性。方法 :对 9例联合应用 FK50 6及骁悉 (MMF)的肾移植患者于术后 6～ 8个月停用激素 ,并进行了随访。结果 :9例患者无急性排斥反应发生 ,大多数激素引起的症状改善。结论 :在 FK50 6和 MMF的基础上逐渐停用激素是安全的。
Objectives: To investigate the possibility of avoiding long-term use of hormones in kidney transplant recipients. Methods: Nine patients with renal transplantation who were treated with FK50 6 and MMF (MMF) were given corticosteroids 6 months to 8 months after operation and were followed up. Results: Nine patients had no acute rejection and most of the hormones improved the symptoms. Conclusion: It is safe to gradually withdraw the hormone on the basis of FK50 6 and MMF.